✦ LIBER ✦

Phase I study for poor-prognosis lymphoma: Augmentation of the “BEAM” regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation — a preliminary report

✍ Scribed by G.L. Phillips II; C.N. Abboud; S.H. Bernstein; J.W. Friedberg; J.J. Ifthikharuddin; J.E. Lancet; J.L. Liesveld; E. Spreng; V. Johnson; M. Chapman; D.H. Vesole

Book ID: 114473696
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 82 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.12.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four versus six courses of a dose-escala

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation : Early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma

✍ Nobert Schmitz; Marita Kloess; Marcel Reiser; Wolfgang E. Berdel; Bernd Metzner; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB